Skip to main content

Table 2 Univariate statistics for items generated to measure patient perceptions about osteoporosis pharmacotherapy, N = 871

From: Measuring patient perceptions about osteoporosis pharmacotherapy

  

Distribution

Response Frequency (%)

Item

 

mean

SD

1

2

3

4

5

1

Drug treatments can help to build strong bones

3.49

0.66

0.1

8.5

33.6

57.6

0.1

2

You would feel good about taking drug treatments to prevent osteoporosis

3.14

0.91

1.0

31.8

19.9

46.7

0.6

3

Drug treatments can cut down the chances of broken bones

3.45

0.67

0.2

9.2

35.9

54.3

0.3

4

You would feel good about taking drug treatments to prevent broken bones

3.14

0.92

1.3

31.9

19.3

47.0

0.6

5

You would consider taking drug treatments to prevent osteoporosis

3.31

0.88

0.5

26.1

16.3

56.6

0.6

6

You would consider taking drug treatments to prevent broken bones

3.31

0.88

0.5

25.9

16.3

56.7

0.6

7

Drug treatment for osteoporosis cost too much*

2.58

0.59

0.3

46.5

48.3

4.7

0.1

8

You are taking too many* medications

2.17

0.72

10.4

71.3

9.6

8.5

0.1

9

You have stomach problems that limit your ability to take drug treatment

2.13

0.47

0.7

89.9

4.9

4.4

0.1

10

Taking drug treatments would upset your every day routine

2.32

0.65

0.5

75.9

14.7

8.7

0.2

11

If your doctor advised you to, you would take drug treatments to prevent broken bones

3.64

0.62

0.2

6.3

23.2

69.5

0.8

12

If your doctor told you that you were at high risk, you would consider taking drug treatments to prevent osteoporosis

3.81

0.64

0.3

4.8

15.5

72.6

6.8

13

If your doctor told you that you were at high risk, you would consider taking drug treatments to prevent broken bones

3.81

0.64

0.3

4.6

15.8

72.4

6.8

  1. 1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree.
  2. * Underlined words may be value-laden or vague.
  3. Item has poor discriminative ability, i.e., >80% of respondents disagree (disagree or strongly disagree) with the statement.
  4. Data available for 870 participants.